The Sodium Pump α1 Subunit as a Potential Target to Combat Apoptosis-Resistant Glioblastomas

Kleihues, 2000, Pathology and Genetics of Tumours of the Nervous System Lefranc, 2005, Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis, J Clin Oncol, 23, 2411, 10.1200/JCO.2005.03.089 Lefranc, 2006, Present and potential future issues in glioblastoma treatment, Expert Rev Anticancer Ther, 6, 719, 10.1586/14737140.6.5.719 Berens, 1999, “…those left behind.” Biology and oncology of invasive glioma cells, Neoplasia, 1, 208, 10.1038/sj.neo.7900034 Stupp, 2005, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330 Giese, 2003, Cost of migration: invasion of malignant gliomas and implications for treatment, J Clin Oncol, 21, 1624, 10.1200/JCO.2003.05.063 Hoelzinger, 2005, Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets, Neoplasia, 7, 7, 10.1593/neo.04535 Okada, 2004, Pathways of apoptotic and non-apoptotic death in tumour cells, Nat Rev Cancer, 4, 592, 10.1038/nrc1412 Lefranc, 2006, Autophagy, the Trojan horse to combat glioblastomas, Neurosurg Focus, 20, 7, 10.3171/foc.2006.20.4.4 Hegi, 2004, Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide, Clin Cancer Res, 10, 1871, 10.1158/1078-0432.CCR-03-0384 Kanzawa, 2004, Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells, Cell Death Differ, 11, 448, 10.1038/sj.cdd.4401359 Sontheimer, 2003, Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage, Trends Neurosci, 26, 543, 10.1016/j.tins.2003.08.007 Ransom, 2001, Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells, J Neurosci, 21, 7674, 10.1523/JNEUROSCI.21-19-07674.2001 Hayashi, 2007, Regulation and function of aquaporin-1 in glioma cells, Neoplasia, 9, 777, 10.1593/neo.07454 Espinada, 2004, Repression of Na,K-ATPase β1-subunit by the transcription factor Snail in carcinoma, Mol Biol Cell, 15, 1364, 10.1091/mbc.E03-09-0646 Barwe, 2005, Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility, Mol Biol Cell, 6, 1082, 10.1091/mbc.E04-05-0427 Mijatovic, 2007, The alpha-1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers, J Pathol, 212, 170, 10.1002/path.2172 Mijatovic, 2007, Cardiotonic steroids on the road to anti-cancer therapy, Biochim Biophys Acta, 1776, 32 Senner, 2003, AMOG/beta2 and glioma invasion: does loss of AMOG make tumour cells run amok?, Neuropathol Appl Neurobiol, 29, 370, 10.1046/j.1365-2990.2003.00473.x Lefranc, 2007, Targeting the α1 subunit of the sodium pump (the Na+/K+-ATPase) to combat glioblastoma cells, Neurosurgery Pelloski, 2006, Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma, Clin Cancer Res, 12, 3935, 10.1158/1078-0432.CCR-05-2202 Koul, 2006, Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma, Mol Cancer Ther, 5, 637, 10.1158/1535-7163.MCT-05-0453 Koul, 2006, PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells, Biochem Biophys Res Commun, 350, 463, 10.1016/j.bbrc.2006.09.077 Wiencke, 2007, Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastomas, Neuro Oncol, 9, 271, 10.1215/15228517-2007-003 Rao, 2005, Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells, Neoplasia, 7, 921, 10.1593/neo.05361 Koul, 2007, PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway, Mol Cell Biochem, 300, 77, 10.1007/s11010-006-9371-8 Newton, 2004, Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors, Expert Rev Anticancer Ther, 4, 105, 10.1586/14737140.4.1.105 O'Rourke, 2004, Targeted molecular therapy in glial tumors, Neurosurgery, 54, N9, 10.1227/01.NEU.0000309633.00854.FD Knobbe, 2003, Genetic alterations and aberrant expression of genes related to the phosphatidylinositol-3-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas, Brain Pathol, 13, 507, 10.1111/j.1750-3639.2003.tb00481.x Chakravarti, 2004, The prognostic significance of phosphatidylinositol-3-kinase pathway activation in human gliomas, J Clin Oncol, 22, 1926, 10.1200/JCO.2004.07.193 Narita, 2002, Mutant epidermal growth factor receptor signalling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas, Cancer Res, 62, 6764 Choe, 2003, Analysis of the phosphatidylinositol 3-kinase signalling pathway in glioblastoma patients in vivo, Cancer Res, 63, 2742 Joy, 2003, Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis, J Cell Sci, 116, 4409, 10.1242/jcs.00712 Shingu, 2003, Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells, Cancer Res, 63, 4044 Shingu, 2003, Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor, J Neurosurg, 98, 154, 10.3171/jns.2003.98.1.0154 Nagai, 2002, Aberrant nuclear factor-kappaB and its participation in the growth of human malignant astrocytomas, J Neurosurg, 96, 909, 10.3171/jns.2002.96.5.0909 Aggarwal, 2004, Nuclear factor-kappaB: the enemy within, Cancer Cel, 6, 203, 10.1016/j.ccr.2004.09.003 Baldwin, 2001, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB, J Clin Invest, 107, 241, 10.1172/JCI11991 Sekulic, 2000, A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogenstimulated and transformed cells, Cancer Res, 60, 3504 Hu, 2005, mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma, Neoplasia, 7, 356, 10.1593/neo.04595 Lefranc, 2007, Pro-autophagic drugs: a novel means to combat apoptosis-resistant cancers, Oncologist, 12, 1395, 10.1634/theoncologist.12-12-1395 Kondo, 2005, The role of autophagy in cancer development and response to therapy, Nat Rev Cancer, 5, 726, 10.1038/nrc1692 Takeuchi, 2005, Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors, Cancer Res, 65, 3336, 10.1158/0008-5472.CAN-04-3640 Eshleman, 2002, Inhibition of the mammalian target of rapamycin sensitises U87 xenografts to fractionated radiation therapy, Cancer Res, 62, 7291 Groves, 2007, A North American Brain Tumor Consortium, (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme, J Neurooncol, 81, 271, 10.1007/s11060-006-9225-y Kanzawa, 2003, Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide, J Neurosurg, 99, 1047, 10.3171/jns.2003.99.6.1047 Eoli, 2007, Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival, Clin Cancer Res, 13, 2606, 10.1158/1078-0432.CCR-06-2184 Roos, 2007, Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine, Oncogene, 26, 186, 10.1038/sj.onc.1209785 Maiuri, 2007, Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nat Rev Mol Cell Biol, 8, 741, 10.1038/nrm2239 Barnburg, 2002, ADF/cofilin and actin dynamics in disease, Trends Cell Biol, 12, 598, 10.1016/S0962-8924(02)02404-2 Denker, 2002, Ion transport proteins anchor and regulate the cytoskeleton, Curr Opin Cell Biol, 14, 214, 10.1016/S0955-0674(02)00304-6 Lefranc, 2006, Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma [Review], Int J Oncol, 28, 1021 Lefranc, 2005, Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiform orthotopic xenografts, J Neurosurg, 102, 706, 10.3171/jns.2005.102.4.0706 LeMercier, 2007, Decreasing galectin-1 expression in human experimental glioblastomas impairs the endoplasmic reticulum stress (ERS) response and increases temozolomide anti-tumor effects [Abstract], AACR Camby, 2006, Galectin-1: a small protein with major functions, Glycobiology, 16, 137R, 10.1093/glycob/cwl025 Megalizzi, 2007, 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs, Neoplasia, 9, 358, 10.1593/neo.07130 Sjostrom, 2007, SIK1 is part of a cell sodium-sensing network that regulates active sodium transport through a calcium-dependent process, Proc Natl Acad Sci USA, 104, 16922, 10.1073/pnas.0706838104 Xie, 2002, Na(+)/K(+)-ATPase as a signal transducer, Eur J Biochem, 269, 2434, 10.1046/j.1432-1033.2002.02910.x Blanco, 2005, NaK-ATPase subunit heterogeneity as a mechanism for tissuespecific ion regulation, Semin Nephrol, 25, 292, 10.1016/j.semnephrol.2005.03.004 Xie, 2003, Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function, Mol Interv, 3, 157, 10.1124/mi.3.3.157 Ye, 1999, Glioma cells release excitotoxic concentrations of glutamate, Cancer Res, 59, 4383 Takano, 2001, Glutamate release promotes growth of malignant gliomas, Nat Med, 7, 1010, 10.1038/nm0901-1010 Arcella, 2005, Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo, Neuro Oncol, 7, 236, 10.1215/S1152851704000961 Munhoz, 2005, Glutamate modulates sodium-potassium-ATPase through cyclic GMP and cyclic GMP-dependent protein kinase in rat striatum, Cell Biochem Funct, 23, 115, 10.1002/cbf.1217 Stenkwist, 2001, Cardenolides and cancer, Anticancer Drugs, 12, 635, 10.1097/00001813-200108000-00012 McConkey, 2000, Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinomas cells, Cancer Res, 60, 3807 Huang, 2004, Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells, Biochem Pharmacol, 67, 727, 10.1016/j.bcp.2003.10.013 Mijatovic, 2006, The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells, Mol Cancer Ther, 5, 391, 10.1158/1535-7163.MCT-05-0367 Van Quaquebeke, 2005, Identification of a novel cardenolide (2′-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses, J Med Chem, 48, 849, 10.1021/jm049405a Mijatovic, 2007, UNBS1450: a new hemi-synthetic cardenolide with promising anticancer activity, Drug Dev Res, 68, 164, 10.1002/ddr.20178 Mijatovic, 2006, Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers, Neoplasia, 8, 402, 10.1593/neo.05850 Stettner, 2005, Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells, Cancer Res, 65, 5535, 10.1158/0008-5472.CAN-04-3688 Gloor, 1990, The adhesion molecule on glia (AMOG) is a homologue of the β subunit of the Na,K-ATPase, J Cell Biol, 110, 165, 10.1083/jcb.110.1.165 Schmalzing, 1992, The adhesion molecule on glia (AMOG/β2) and α1 subunits assemble to functional sodium pumps in Xenopus oocytes, J Biol Chem, 267, 20212, 10.1016/S0021-9258(19)88688-X Navarro, 2004, A role for caveolae in cell migration, FASEB J, 18, 1801, 10.1096/fj.04-2516rev Robins, 2006, Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021, Neuro Oncol, 8, 47, 10.1215/S1522851705000311 Brandes, 2006, Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma, Neuro Oncol, 8, 253, 10.1215/15228517-2006-005 Branle, 2002, Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy, Cancer, 95, 641, 10.1002/cncr.10710 Belot, 2001, The molecular characterization of cell-substratum attachments in human glial tumors relates to prognostic features, Glia, 36, 375, 10.1002/glia.1124 Lefranc, 2003, Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas, Neurosurgery, 52, 881, 10.1227/01.NEU.0000053366.00088.80 Molitoris, 1991, Dissociation and redistribution of Na+,K+-ATPase from its surface membrane actin cytoskeleton complex during cellular ATP depletion, J Clin Invest, 88, 462, 10.1172/JCI115326 Lum, 2005, Autophagy in metazoans: cell survival in the land of plenty, Nat Rev Mol Cell Biol, 6, 439, 10.1038/nrm1660 Lopez-Lazaro, 2005, Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients, J Nat Prod, 68, 1642, 10.1021/np050226l